Beta Bionics Inc BBNX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
BBNX Deadline: BBNX Investors Have Opportunity to Lead Beta Bionics, Inc. Securities Fraud Lawsuit
BBNX Deadline Today: Rosen Law Firm Urges Beta Bionics, Inc. (NASDAQ: BBNX) Stockholders to Contact the Firm for Information About Their Rights
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Beta Bionics (NASDAQ: BBNX) Investors of Securities Class Action Lawsuit Deadline on November 3, 2026
Beta Bionics 96 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Beta Bionics, Inc. - BBNX
BBNX SHAREHOLDER NOTICE: Beta Bionics Investors with Substantial Losses Have Opportunity to Lead Securities Class Action
BBNX Deadline: BBNX Investors Have Opportunity to Lead Beta Bionics, Inc. Securities Fraud Lawsuit
BBNX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Beta Bionics, Inc. Securities Lawsuit - Contact SueWallSt
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Beta Bionics, Inc. of Class Action Lawsuit and Upcoming Deadlines - BBNX
Trading Information
- Previous Close Price
- $15.70
- Day Range
- $15.57–17.04
- 52-Week Range
- $8.80–32.71
- Bid/Ask
- $13.10 / $18.00
- Shares Outstanding
- 54.37M
- Market Cap
- $921.52M
- Volume/Avg
- 656,519 / 1M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 5.98
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 423
- Website
- https://www.betabionics.com
Valuation
Metric | BBNX |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.29 |
Price/Sales | 5.98 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | BBNX |
|---|---|
Quick Ratio | 8.04 |
Current Ratio | 8.92 |
Interest Coverage | — |
Quick Ratio
BBNX
Profitability
Metric | BBNX |
|---|---|
Return on Assets (Normalized) | −17.52% |
Return on Equity (Normalized) | −19.70% |
Return on Invested Capital (Normalized) | −22.33% |
Return on Assets
BBNX
Medical Devices Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|s<XXHR | LOCK|?HVZ | $191B | |||
| Medtronic PLC MDT | LOCK|<?SV?m | LOCK|%kljK | $131B | |||
| Stryker Corp SYK | LOCK|@$bq#&& | LOCK|^$# | $124B | |||
| Boston Scientific Corp BSX | LOCK|?R#@<> | LOCK|wMDq | $64B | |||
| Edwards Lifesciences Corp EW | LOCK|#WmDX!& | LOCK|yNm< | $60B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|RT%%K& | LOCK|y!Y | $38B | |||
| DexCom Inc DXCM | LOCK|W&X%d?Y! | LOCK|<pFw | $30B | |||
| Koninklijke Philips NV ADR PHG | LOCK|pwN | LOCK|RGt | $30B | |||
| Steris PLC STE | LOCK|w#wvD^! | LOCK|wvBRL | $25B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|M^&&Tn# | LOCK|?V | $21B |
United States